From breast cancer to Alzheimer's, we want to give everyone access to affordable and accurate diagnostic tools and healthcare information.Watch Video About Our Beginning Released by Google LLC
A company developing innovative data-driven AI technology solutions for the healthcare industry.
Founded by Abu Qader and Vedad Mešanović, two entrepreneurs that were called "the next Jobs and Wozniak", GliaLab won numerous rewards like "Startup of the Year" and "Best AI Solution", and secured support from companies like NVIDIA on its mission to deliver top-tier healthcare to third world countries.
We work with industry experts to improve diagnostic outcomes, reduce the cost of healthcare, and support physicians and patients with smart technology solutions.
A global diagnostic healthcare platform utilizing AI and blockchain technologies to provide users with universal and safe remote access to next-gen diagnostic tools and advice.
Every year, misdiagnoses of illnesses result in unnecessary or inappropriate treatments, deaths, lawsuits, and billions of dollars in additional expenses burdening the healthcare system. Furthermore, third world countries lack access to world-class healthcare tools.
GLIA Tokens (ERC20) are access-based utility tokens functioning as credits within the GliaBase platform that users will be using to access our diagnostic tools.
June 1, 2018
30,000,000 GLIA (30%)
July 1, 2018
GliaLab was born with a mission to improve healthcare.
GliaLab selected as
"Best AI Solution" at the Central European
Chris Mone, a businessman and the founder of Mone Capital, joins GliaLab.
GliaLab selected by the IBM Watson AI XPRIZE team to develop and
use AI to tackle some
of the world’s greatest challenges.
Google CEO, Sundar Pichai, plays a short movie and talks about our co-founder Abu Qader during his keynote speech at the Google I/O conference.
GliaLab selected by NVIDIA as a partner
for Inception Program nurturing dedicated
startups who are revolutionizing
industries with AI.
GliaLab launches GliaX R&D division focused on technologies like computer vision and blockchain.
and CTO spoke at the O’Reilly Artificial Intelligence
Conference with Peter Norvig, a director of research at Google.
After being selected as "Startup of the Year", our co-founder spoke at the MiSK Global Forum with other notable speakers like Bill Gates and Princess Reema bint Bandar.
Token sale to launch GliaBase, a global diagnostic healthcare platform for various diseases.
GliaBase is launched, strategic partnerships are formed, and new diagnostic tools are being developed.
Passionate people with diverse backgrounds and experience who share a vision and a common belief that we can use new technologies to improve the human race.
Chief Executive Officer
Having worked with one of the world's leading investment management organizations, Chris brings extensive C-Suite and industry experience to the team.
He is the founder of Mone Capital and a private angel investor in several technology companies. Chris was also an Adjunct Professor at the Northwestern University in Evanston, Illinois.
Chief Operating Officer
Vedad has significant and diverse industry experience working with local and international organizations, as well as working for companies and startups as an advisor, sales and marketing representative, and business development officer.
He is also the Ambassador of the Central European Startup Awards and a member of CSRPlus, a consultancy agency for CSR.
Chief Technology Officer
Abu is a driven developer whose main focus of interest is the usage of AI to solve current dilemmas our society faces. By the age of 15, he was a machine learning assistant at the Conte Research Institute at the University of Chicago.
Among many achievements, he was recently selected by the We Are Family Foundation and SAP as one of the 2018 Three Dot Dash Global Teen Leaders, a list of changemakers taking global issues in their own hands.
CEO at Leviathan Security
Frank is a recognized expert in the fields of information assurance, network security, and systems penetration. Prior to forming Leviathan, Frank was a Managing Security Architect for @stake and headed up their Pacific Northwest practice.
He also engaged in various computer security-related work for the Department of Defense and has been a Visiting Lecturer at the United States Army War College.
President & CEO at Ioppolo Law Group
Frank’s practice involves a variety of business, securities, financing, advertising, and regulatory matters focusing on public and private financing transactions, mergers and acquisitions, securities, and compliance issues. He was recognized by the Florida Trend Magazine as one of the 2% of all lawyers in Florida.
He also served as the Chief Operating Officer of a nearly $40,000,000 performance marketing company with more than 60 employees.
Vice Chairman at Department of General Surgery at North Shore University Hospital
Dr. Procaccino is Vice Chairman at the Department of General Surgery, Director at the Center for Colon and Rectal Diseases and the Colon and Rectal Fellowship, and Chief of Division of the Colon and Rectal Surgery at the North Shore University Hospital.
In Castle Connolly’s estimation, Dr. Procaccino is among the top 1% in the nation in his specialty, and is generally recognized as one of the leaders in the field.
Founder at Writinado
Jasmin is an award-winning educator, author and seasoned copywriter from Bosnia and Herzegovina. He is the founder of Writinado, a content creation solutions provider for enterprises, SMBs, and influencers around the world.
Apart from his background as an acknowledged EFL teacher, he is also an SAT trainer and a German course instructor, with work experience in Bosnia and Herzegovina, Germany, and the Kingdom of Saudi Arabia.
CEO at Veles.co & Founder at Binfluence.rs
Kristijan is a serial entrepreneur, startup advisor, and sales professional. He is the founder at Veles, a sales and business matchmaking services company working with different clients around the world.
He is the co-founder at Sixpence, a mobile payments crowdfunding platform for a new generation of businesses and millennials. Kristijan received a Bachelor degree in Computer Sciences in Belgrade and pursued a Master’s degree in Boston at the Hult International Business School.
Chapter Director at Startup Grind & Country Manager at Dash Digital Cash
Nebojša is Chapter Director at Startup Grind, the largest independent startup community, actively educating, inspiring, and connecting more than 1,000,000 entrepreneurs in over 365 cities through events, media, and partnerships with organizations like Google for Entrepreneurs.
He is also a Country Manager at Dash Digital Cash, an open source peer-to-peer cryptocurrency.
Head of full-stack development at GliaLab Inc.
Alexander is a computer scientist with hands-on technical skills, as well as proven management and development expertise from entities like Deloitte, Ciklum, Unicredit Group, The Boston Consulting Group etc.
Alexander is also the founder of DataYield GmbH, a development firm, and a partner at Evolvice Team GmbH.
If you have any other questions, please get in touch using the contact form below.
Our vision is to deliver global, secure, and affordable access to top-tier medicine to people around the world in the form of diagnostic tools powered by state-of-the-art algorithms.
Nazako is a diagnostic algorithm for breast cancer developed by GliaLab. We have entered into an NDA with a global publicly traded manufacturer of diagnostic imaging systems who has expressed interest in the capabilities and features of the system.
As a recognized company with multiple achievements and a strong industry presence, GliaLab has the potential to save lives and turn GliaBase into a highly regarded resource in local, regional, national, and international healthcare markets.
The funds raised through our token sale will be distributed among development, hiring costs and forming partnerships with medical institutions, universities and influential technology companies like NVIDIA.
GLIA Tokens are access-based utility tokens functioning as credits within the GliaBase platform that users will be using to access and use our diagnostic tools.
Our long-term vision includes partnering with other healthcare companies that will be accepting GLIA Tokens as utility tokens within their platform and, in return, get to use our algorithms for free.
We will release 100 million GLIA Tokens. 30% will be available for purchase during our campaign. All Unsold GLIA Tokens will be burned.
No, GLIA tokens are not securities. Please read our Whitepaper and Sales Agreement for more information.
GLIA tokens are not an investment. They are utility tokens allowing users to explore diagnostic features within the GliaBase platform. They are not for speculative investment.
It is the responsibility of solely Buyer to determine if Buyer can legally purchase the Tokens in his jurisdiction.
Ownership of the Tokens carries no rights, express or implied, other than the right to use the Tokens within the GliaBase platform.
GLIA tokens are not participation in GliaLab company and GLIA tokens hold no rights in said Company.
Any questions or ideas? Reach out to us and we’ll get back to you shortly.